Thu, 17 November 2016
Several years ago, I gave my take on the “personalized care” movement: the broad push to use a person’s genetic data to design optimal therapies, treatments, interventions, and pharmaceuticals. I was supportive and hesitantly optimistic, but I also acknowledged the limitations and drawbacks. Yes, genetics do determine how we respond to different therapies, and we can optimize medical care using the information—if we understand what our genes are saying and how they interact with the environment.
(This Mark's Daily Apple article was written by Mark Sisson, and is narrated by Tina Leaman)
Direct download: MDA-Nov112016-PromisesAndLimitationsOfThePersonalizedCareMovement.mp3
Category:general -- posted at: 12:00pm PDT